New book by Larry Connors Click here Improve your trading - See how
During the trial, participants are provided with easy-to-use equipment to take daily measurements that are automatically transmitted via mobile phone to a secure online database monitored by the ADHB cardiac team. The equipment also lets patients monitor their own readings. The more frequent data collection will enable medical personnel to more quickly discover changes in health status, enabling quicker medical intervention when necessary, while making more productive use of face-to-face appointments. Once the initial trial results have been assessed, ADHB hopes to extend the program to patients with other chronic illnesses like diabetes.
Worldwide, remote patient monitoring technology is emerging as a cost and time effective tool to keep people with chronic conditions well and out of the hospital. The Alcatel-Lucent TeleHealth Manager allows patients to provide health data using devices they're already familiar with (e.g., mobile phones) in a secure manner, while also providing reminders, alerts and online reports to help patients and their healthcare professionals better understand and manage their conditions. Gen-i is integrating the project's delivery technologies and ADHB is supporting the medical care team with patient care specifications and training.
Auckland District Health Board Chief Funding and Planning Officer, Dr Denis Jury, says the innovative Telehealth monitoring system could improve health outcomes and enhance patients' quality of life, while reducing costs and increasing clinical efficiencies for health providers. "The technology is emerging as a cost and time effective tool worldwide to help keep people with long term conditions well and out of hospital," said Dr Jury.
Chris Quin, CEO of Gen-i, explains that faced with rapidly increasing numbers of patients with chronic illnesses, the health sector is looking for ways to consolidate specialists' time and relieve pressure on them. "The Telehealth initiative combats both these issues while also providing positive health outcomes for patients. Gen-i and Telecom are well placed with the scale, technology and infrastructure to support the solution nationwide and through Gen-i's existing relationships with DHBs and other health organisations.
Quin adds that mobile technologies provide a simple and cost effective platform for this approach. "Patients and health professionals are likely to be familiar with how to use a mobile phone, so set up and training is straight forward. The process is completed in a matter of seconds, providing near real-time monitoring and response," he adds.
Alcatel-Lucent continues to offer innovative communications solutions for the healthcare industry and leverages its relationships by working with service providers and medical providers throughout the world to enable enhanced patient care. "Alcatel-Lucent's work with Gen-i offers these trial patients a secure and reliable remote patient monitoring service that will afford them greater flexibility in the way that they manage their health and recovery, and we are confident that this application will prove beneficial to them and will be able to be replicated at many other medical centres," said Steve Lowe, Head of Alcatel-Lucent's business in New Zealand.
More information about Alcatel-Lucent solutions for the healthcare industry is available online.
About Gen-i
Gen-i is at the forefront of helping customers take advantage of the convergence of technology and telecommunications, and the new opportunities this makes possible. Gen-i works alongside its 3,300 corporate, government and business customers to deliver seamless and integrated ICT solutions. A member of the Telecom New Zealand Group, Gen-i achieves this with the support of over 3,000 highly skilled people in 17 locations across New Zealand and Australia. For more information on Gen-i, visit www.gen-i.co.nz
Copyright Hugin
Information réglementée : Type : Nouvelle information Thème(s): Communiqués au titre de l'obligation d'information permanente - Autres communiqués
This announcement is originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
[CN#160063]
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
